Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-10-12

Clinical Trial Update: Study on Efficacy and Safety of CaReSR-1S to Repair Cartilage Defects of the Knee [NA]

View source ↗

Summary

Clinical trial update for CaReSR-1S aimed at repairing knee cartilage defects; the trial status is not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CaReSR-1S

Snippet

Sponsor: Arthro-Anda Tianjin Biologic Technology Co., Ltd. | Conditions: Cartilage Defects | NA | Status: UNKNOWN